Accès gratuit
Numéro
Med Sci (Paris)
Volume 29, Numéro 1, Janvier 2013
Page(s) 22 - 25
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2013291007
Publié en ligne 25 janvier 2013
  1. Burton DR, Poignard P, Stanfield RL, Wilson IA. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 2012 ; 337 : 183–186. [CrossRef] [PubMed]
  2. Corti D, Voss J, Gamblin ST, et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011 ; 333 : 850–856. [CrossRef] [PubMed]
  3. Dreyfus C, Laursen NS, Kwaks T, et al. Highly conserved protective epitopes on influenza B viruses. Science 2012 ; 337 : 1343–1348. [CrossRef] [PubMed]
  4. Ekiert DC, Bhabha G, Elsliger MA, et al. Antibody recognition of a highly conserved influenza virus epitope. Science 2009 ; 324 : 246–251. [CrossRef] [PubMed]
  5. Ekiert DC, Friesen RH, Bhabha G, et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 2011 ; 333 : 843–850. [CrossRef] [PubMed]
  6. Sui J, Hwang WC, Perez S, et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Biol 2009 ; 16 : 265–273. [CrossRef]
  7. McCullers JA, Saito T, Iverson AR. Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol 2004 ; 78 : 12817–12828. [CrossRef] [PubMed]
  8. Throsby M, van den Brink E, Jongeneelen M, et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1, H1N1 recovered from human IgM+ memory B cells. PLoS One 2008 ; 3 : e3942. [CrossRef] [PubMed]
  9. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004 ; 292 : 1333–1340. [CrossRef] [PubMed]
  10. Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet 2000 ; 355 : 827–835. [CrossRef] [PubMed]
  11. Hessell AJ, Hangartner L, Hunter M, et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 2007 ; 449 : 101–104. [CrossRef] [PubMed]
  12. Fleishman SJ, Whitehead TA, Ekiert DC, et al. Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science 2011 ; 332 : 816–821. [CrossRef] [PubMed]
  13. Whitehead TA, Chevalier A, Song Y, et al. Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing. Nat Biotechnol 2012 ; 30 : 543–548. [CrossRef] [PubMed]
  14. Bao Y, Bolotov P, Dernovoy D, et al. The influenza virus resource at the National Center for Biotechnology Information. J Virol 2008 ; 82 : 596–601. [CrossRef] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.